PureCycle Technologies/$PCT
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About PureCycle Technologies
PureCycle Technologies Inc is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology), originally developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin. PureFive resin represents the family of recycled resin products produced, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene. It has a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins.
- Ticker
- $PCT
- Sector
- Materials
- Primary listing
- NASDAQ
- Employees
- 174
- Headquarters
- Orlando, United States
- Website
- www.purecycle.com
PCT Metrics
BasicAdvanced
$677M
-
-$1.48
2.58
-
Price and volume
Market cap
$677M
Beta
2.58
52-week high
$14.20
52-week low
$2.59
Average daily volume
6.6M
Financial strength
Current ratio
2.602
Quick ratio
2.301
Long term debt to equity
1.587
Total debt to equity
1.63
Interest coverage (TTM)
-2.66%
Profitability
EBITDA (TTM)
-136.923
Gross margin (TTM)
-782.77%
Net profit margin (TTM)
-1,618.84%
Operating margin (TTM)
-1,207.32%
Effective tax rate (TTM)
-0.44%
Revenue per employee (TTM)
$80,000
Management effectiveness
Return on assets (TTM)
-10.16%
Return on equity (TTM)
-61.55%
Valuation
Price to revenue (TTM)
44.25
Price to book
43.68
Price to tangible book (TTM)
43.68
Price to free cash flow (TTM)
-2.87
Free cash flow yield (TTM)
-34.85%
Free cash flow per share (TTM)
-1.171
Growth
Revenue change (TTM)
326.13%
Earnings per share change (TTM)
-12.49%
3-year earnings per share growth (CAGR)
23.96%
What the Analysts think about PCT
Analyst ratings (Buy, Hold, Sell) for PureCycle Technologies stock.
Analyst projections of the future price of PureCycle Technologies stock.
Bulls say / Bears say
PureCycle has moved beyond samples: select Downy caps made with PureFive resin entered commercial production for Procter & Gamble, while Tide and Vicks applications are scheduled to follow. Revenue reached $4.5 million in Q2, the sixth consecutive quarter of sequential growth. (Nasdaq)
The Ironton turnaround finished ahead of schedule and below budget, and the plant later demonstrated throughput of 12,000 pounds per hour. That points to improved operating capability, although it is not yet a routine production rate. (The Motley Fool)
New Jersey approved PureFive as recycled content as its 2027 requirements approach, and management says the decision has accelerated customer qualification. That could turn regulatory compliance into near-term demand for recycled polypropylene. (The Motley Fool)
Commercial scale remains unproven: Q2 PureFive production was 4.5 million pounds, while revenue was just $4.5 million. The plant’s planned turnaround explains some of the subdued output, but Ironton still has to show it can sustain a much larger ramp. (Nasdaq)
Losses remain far larger than sales: PureCycle reported a $142.2 million net loss and negative $31.7 million adjusted EBITDA for Q2. Its hoped-for Ironton cash breakeven is still a second-half target, not an achieved result. (Resource Recycling)
The June funding improved liquidity but came with dilution: the company issued about 19.9 million shares alongside $287.5 million of convertible notes. It also raised its 2026 project-spending outlook to $45–50 million, while financing for the planned $250 million Thailand facility remained under negotiation. (Nasdaq, The Motley Fool)
Data summarised monthly by Lightyear AI. Last updated on 14 Oct 2026.
PCT Financial Performance
Revenues and expenses
PCT Earnings Performance
Company profitability
Upcoming events
No upcoming events
PCT News
AllArticlesVideos
Funds containing PCT
Fund name | Fund size | $PCT weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap£R2SC | $5.3B | 0.02% |
SPDR Russell 2000 US Small Cap€R2US | $5.3B | 0.02% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | $3.2B | 0.01% |
iShares MSCI USA Small Cap CTB Enhanced ESG£CUS1 | $3.2B | 0.01% |
Xtrackers MSCI World Small Cap$XSWC | $183M | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.